Piracetam: a review of pharmacological properties and clinical uses

This comprehensive review examined over 100 studies investigating piracetam's effects on cognitive function, including both animal and human research. Piracetam, the original nootropic compound, has been studied extensively for over 40 years.

The review found consistent evidence that piracetam improves cognitive function in patients with cognitive impairment, including those with dementia, stroke, and age-related decline. Effects include enhanced memory, learning, attention, and overall cognitive performance. Typical therapeutic doses range from 1.2 to 4.8 grams daily.

Piracetam appears to work through multiple mechanisms, including improving neuronal membrane fluidity, enhancing neurotransmitter function, and increasing cerebral blood flow. The compound has an excellent safety profile with minimal side effects even at high doses. While benefits are well-established in cognitively impaired populations, effects in healthy adults remain less clear and require further research.